Ray Therapeutics Grant · $4M raised · (2022)

Ray Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies to restore vision for individuals suffering from severe retinal degenerations. Their approach aims to address unmet medical needs in ophthalmology.